The most common tissue expander-related infections are from Staphylococcus and Pseudomonas species. In addition, from breast tissue microbiome studies, Staphylococcus and Pseudomonas show variable abundance across samples. The investigator hypothesizes that participants undergoing mastectomy with high initial abundance of Staphylococcus and/or Pseudomonas are more likely to develop subsequent tissue expander-related infections from these respective organisms.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of tissue samples obtained successfully over time
Timeframe: 90 days
Proportion of aspirate samples obtained successfully overall
Timeframe: 90 days
Proportion of tissue samples successfully producing microbiome data
Timeframe: 90 days
Proportion of aspirate samples successfully producing microbiome data
Timeframe: 90 days
Proportion of any samples successfully producing microbiome data
Timeframe: 90 days
Correlation of the change in breast microbiome over time with total duration of antibiotics (Cohort A only)
Timeframe: 90 days